Pipeline

Building regenerative treatments for women's health

Our co-development approach has made it as broad as it is deep – letting us advance select opportunities ourselves while partnering on others.

Program

In Vitro

Preclinical

Phase 1

MenSC™-101

Partner:
Undisclosed Target:
Undisclosed

Undisclosed

MenSC Labs aims to develop first-in-class therapies for regenerative medicine in women's health — an area traditionally underfunded and underserved. Our pipeline is founded on strong science, translating breakthroughs in MenSC discovery into differentiated treatments.

Where to start

Most partnerships begin with research use material and a characterisation package, then move to a co-development agreement once the data supports it.

Interested in co-developing with us?

Speak to us